Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Effect of Inhaled Aromatherapy on Chemo-Induced Nausea Vomiting (NCVI): CINVAROM (Chemotherapy Induced Nausea Vomiting and AROMatherapy) [Phase 2]
Phase 2 clinical trial evaluating inhaled aromatherapy for chemotherapy-induced nausea and vomiting (CINV) called CINVAROM; the study is com…
-
FDA approval · 2022-11-28FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved the original application for Prochlorperazine Edisylate as a generic antiemetic indicated for relief of nausea and vomiting.
-
FDA approval · 2022-11-02FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic promethazine hydrochloride under an original ANDA. The approval authorizes marketing of the gen…
-
FDA approval · 2022-06-23FDA Approved: ONDANSETRON — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for ondansetron hydrochloride (generic ondansetron) from NorthStar Rx LLC under ANDA078776. The …
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery [Phase 2]
A Phase 2 clinical trial evaluating the effect of ultrasound-guided transversus abdominis plane block after laparoscopic bariatric surgery o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-06-02FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Sandoz, Inc.)
FDA approved chlorpromazine hydrochloride as a generic drug through an original ANDA submitted by Sandoz, Inc.
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients? [Phase 4]
Phase 4 trial evaluating whether intravenous ondansetron reduces itch after intrathecal morphine in pediatric patients has been terminated; …
-
FDA approval · 2020-10-26FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries Inc)
FDA approved a generic version of chlorpromazine hydrochloride under Original Application for Sun Pharmaceutical Industries Inc, expanding a…
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride submitted by Upsher-Smith Laboratories, LLC.
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride (Upsher-Smith Laboratories, LLC), confirming continued approval of …
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HCI — Supplemental Application (Dr. Reddy's Laboratories Inc.,)
FDA approved a supplemental application for chlorpromazine HCl from Dr. Reddy's Laboratories, confirming the generic product's approval unde…
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: The Preventive Effects of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate [Phase 4]
Phase 4 trial update evaluating preventive effects of sub-hypnotic dose propofol on nausea and vomiting induced by Hemabate.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride [Phase 1]
Phase 1 study assessing intra-subject variability in the bioavailability of chlorpromazine hydrochloride. The study is completed and results…
-
FDA approval · 2017-02-23FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approved a supplemental application for Prochlorperazine maleate by Jubilant Cadista Pharmaceuticals Inc.
-
FDA approval · 2017-02-23FDA Approved: COMPRO — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for COMPRO (prochlorperazine) from Padagis US LLC.
-
FDA approval · 2017-02-23FDA Approved: HALOPERIDOL — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for HALOPERIDOL from Lannett Company, Inc., under an Abbreviated New Drug Application (ANDA). Th…
-
FDA approval · 2017-02-23FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Prochlorperazine edisylate from Heritage/Avet Pharmaceuticals, authorizing continued manufacture…
-
FDA approval · 2017-02-23FDA Approved: CHLORPROMAZINE HCI — Supplemental Application (Dr. Reddy's Laboratories Inc.,)
FDA approved a supplemental application for Chlorpromazine HCl by Dr. Reddy's Laboratories Inc., granting approval for a generic version of …
-
FDA approval · 2016-08-29FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC. This action confirms approval …
-
FDA approval · 2015-06-09FDA Approved: TRIMETHOBENZAMIDE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for trimethobenzamide hydrochloride. This action authorizes the changes des…
-
FDA approval · 2015-01-15FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride from Aurobindo Pharma Limited, enabling the generic product to adv…
-
FDA approval · 2014-12-20FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
The FDA approved a supplemental application for ondansetron from West-Ward Pharmaceuticals Corp. (ANDA076780), indicating approval related t…
-
FDA label_change · 2014-12-10FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for metoclopramide submitted by Teva Pharmaceuticals USA, Inc. to modify the drug labeling.
-
FDA approval · 2014-12-08FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for ondansetron hydrochloride by Fresenius Kabi USA, LLC under an ANDA, allowing continued manufactu…
-
FDA approval · 2014-12-08FDA Approved: ONDANSETRON — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for ondansetron submitted by Glenmark Pharmaceuticals Inc., USA.